Literature DB >> 23992005

Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination.

Wen-Jing Wang1, Zhen Tao, Wei Gu, Li-Hua Sun.   

Abstract

OBJECTIVE: To evaluate the association of a diagnosis of lung cancer and combined detection of serum carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), neuron specific enolase (NSE) as well as the cytokeratin 19 fragment (CYFRA21-1).
METHODS: Serum CEA, CA19-9, NSE and CYFRA21-1 were assessed in 150 patients with lung cancer, 100 patients with benign lung disease and 100 normal control subjects, and differences of expression were compared in each group, and joint effects of these tumor markers in the diagnosis of lung cancer were analyzed.
RESULTS: Serum CEA, CA19-9, NSE and CYFRA21-1 in patients with lung cancer were significantly higher than those with benign lung disease and normal controls (p<0.01). It is suggested that these four tumor markers combined together could produce a positive detection rate of 90.2%, significantly higher than that of any single test.
CONCLUSION: Combination detection of CEA, CA19-9, NSE and CYFRA21-1 could significantly improve the sensitivity and specificity in diagnosis of lung cancer, and could be important in early detection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23992005     DOI: 10.7314/apjcp.2013.14.7.4369

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  12 in total

1.  Epidermal growth factor receptor gene mutation status and its association with clinical characteristics and tumor markers in non-small-cell lung cancer patients in Northwest China.

Authors:  Ablajan Abdurahman; Jurat Anwar; Abdugheni Turghun; Madiniyet Niyaz; Liwei Zhang; Idiris Awut
Journal:  Mol Clin Oncol       Date:  2015-05-11

2.  Monitoring with sensitive tumor markers contributes to decision-making and better prognosis in gastric cancer patients with peritoneal recurrence.

Authors:  Takuma Ohashi; Shuhei Komatsu; Daisuke Ichikawa; Toshiyuki Kosuga; Kazuma Okamoto; Tomohiro Arita; Hirotaka Konishi; Ryo Morimura; Yasutoshi Murayama; Atsushi Shiozaki; Yoshiaki Kuriu; Hisashi Ikoma; Masayoshi Nakanishi; Hitoshi Fujiwara; Eigo Otsuji
Journal:  Int J Clin Oncol       Date:  2017-05-09       Impact factor: 3.402

3.  Tumor profiling of co-regulated receptor tyrosine kinase and chemoresistant genes reveal different targeting options for lung and gastroesophageal cancers.

Authors:  Jianzhong Wu; Shuchun Li; Rong Ma; Ashok Sharma; Shan Bai; Boying Dun; Haixia Cao; Changwen Jing; Jinxiong She; Jifeng Feng
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

4.  Establishment of a mathematic model for predicting malignancy in solitary pulmonary nodules.

Authors:  Man Zhang; Na Zhuo; Zhanlin Guo; Xingguang Zhang; Wenhua Liang; Sheng Zhao; Jianxing He
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

5.  Serum anti-MDM2 and anti-c-Myc autoantibodies as biomarkers in the early detection of lung cancer.

Authors:  Pei Li; Jian-Xiang Shi; Li-Ping Dai; Yu-Rong Chai; Hong-Fei Zhang; Mutombo Kankonde; Peggy Kankonde; Bao-Fa Yu; Jian-Ying Zhang
Journal:  Oncoimmunology       Date:  2016-04-22       Impact factor: 8.110

6.  Follistatin is a novel biomarker for lung adenocarcinoma in humans.

Authors:  Fangfang Chen; Ping Ren; Ye Feng; Haiyan Liu; Yang Sun; Zhonghui Liu; Jingyan Ge; Xueling Cui
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

7.  Identification of serum proteins and multivariate models for diagnosis and therapeutic monitoring of lung cancer.

Authors:  Rong Ma; Heng Xu; Jianzhong Wu; Ashok Sharma; Shan Bai; Boying Dun; Changwen Jing; Haixia Cao; Zhuo Wang; Jin-Xiong She; Jifeng Feng
Journal:  Oncotarget       Date:  2017-03-21

8.  [Radio-labeling of T7 peptide with 99mTc and its biodistribution in nude mice bearing non-small cell lung cancer].

Authors:  Yumei Hao; Xin He; Xiaoliang Zhou; Aimin Meng; Jianfeng Liu; Jinjian Liu; Naling Song
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2014-03

9.  A meta-analysis and bioinformatics exploration of the diagnostic value and molecular mechanism of miR-193a-5p in lung cancer.

Authors:  Zu-Cheng Xie; Rui-Xue Tang; Xiang Gao; Qiong-Ni Xie; Jia-Ying Lin; Gang Chen; Zu-Yun Li
Journal:  Oncol Lett       Date:  2018-07-19       Impact factor: 2.967

10.  Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?

Authors:  Qixian Yang; Ping Zhang; Rongqiang Wu; Kefeng Lu; Hongxing Zhou
Journal:  Dis Markers       Date:  2018-10-01       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.